223 related articles for article (PubMed ID: 26990621)
1. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance.
Zhang X; Tian J; Li J; Huang L; Wu S; Liang W; Zhong L; Ye J; Ye F
Br J Pharmacol; 2016 Jun; 173(12):1939-49. PubMed ID: 26990621
[TBL] [Abstract][Full Text] [Related]
2. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
4. CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease.
Li J; Zhang X; Tian J; Li J; Li X; Wu S; Liu Y; Han J; Ye F
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678603
[TBL] [Abstract][Full Text] [Related]
5. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
[TBL] [Abstract][Full Text] [Related]
6. Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.
Maeda A; Kai K; Ishii M; Ishii T; Akagawa M
Mol Nutr Food Res; 2014 Jun; 58(6):1177-89. PubMed ID: 24668740
[TBL] [Abstract][Full Text] [Related]
7. Improved glucose-stimulated insulin secretion by intra-islet inhibition of protein-tyrosine phosphatase 1B expression in rats fed a high-fat diet.
Lu B; Wu H; Gu P; Du H; Shao J; Wang J; Zou D
J Endocrinol Invest; 2012 Jan; 35(1):63-70. PubMed ID: 21646858
[TBL] [Abstract][Full Text] [Related]
8. BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes.
Xu Q; Luo J; Wu N; Zhang R; Shi D
Int J Biol Macromol; 2018 Jan; 106():379-386. PubMed ID: 28811203
[TBL] [Abstract][Full Text] [Related]
9. Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.
Luo J; Xu Q; Jiang B; Zhang R; Jia X; Li X; Wang L; Guo C; Wu N; Shi D
Br J Pharmacol; 2018 Jan; 175(1):140-153. PubMed ID: 29059712
[TBL] [Abstract][Full Text] [Related]
10. Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.
Takada M; Sumi M; Maeda A; Watanabe F; Kamiya T; Ishii T; Nakano M; Akagawa M
Biochem Biophys Res Commun; 2012 Nov; 428(2):315-20. PubMed ID: 23085227
[TBL] [Abstract][Full Text] [Related]
11. Stearic acid serves as a potent inhibitor of protein tyrosine phosphatase 1B.
Tsuchiya A; Kanno T; Nishizaki T
Cell Physiol Biochem; 2013; 32(5):1451-9. PubMed ID: 24296476
[TBL] [Abstract][Full Text] [Related]
12. [The effects of compound CX09040 on the inhibition of PTP1B and protection of pancreatic β cells].
Tang RQ; Zhang XL; Tian JY; Kong SM; Zhou Y; Zhang P; Yang HK; Wu S; Zhang Y; Ye F
Yao Xue Xue Bao; 2015 Jun; 50(6):682-9. PubMed ID: 26521437
[TBL] [Abstract][Full Text] [Related]
13. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
[TBL] [Abstract][Full Text] [Related]
14. Prunin is a highly potent flavonoid from Prunus davidiana stems that inhibits protein tyrosine phosphatase 1B and stimulates glucose uptake in insulin-resistant HepG2 cells.
Jung HA; Ali MY; Bhakta HK; Min BS; Choi JS
Arch Pharm Res; 2017 Jan; 40(1):37-48. PubMed ID: 27798765
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
Jiang B; Luo J; Guo S; Wang L
Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
Ito Y; Fukui M; Kanda M; Morishita K; Shoji Y; Kitao T; Hinoi E; Shirahase H
J Pharmacol Sci; 2018 May; 137(1):38-46. PubMed ID: 29731242
[TBL] [Abstract][Full Text] [Related]
17. Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.
Lees EK; Krol E; Shearer K; Mody N; Gettys TW; Delibegovic M
Metabolism; 2015 Feb; 64(2):305-14. PubMed ID: 25468142
[TBL] [Abstract][Full Text] [Related]
18. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid.
Yang YM; Seo SY; Kim TH; Kim SG
Hepatology; 2012 Dec; 56(6):2209-20. PubMed ID: 22807119
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B.
Li XQ; Xu Q; Luo J; Wang LJ; Jiang B; Zhang RS; Shi DY
Eur J Med Chem; 2017 Aug; 136():348-359. PubMed ID: 28511130
[TBL] [Abstract][Full Text] [Related]
20. Early growth response-1 negative feedback regulates skeletal muscle postprandial insulin sensitivity via activating Ptp1b transcription.
Wu J; Tao WW; Chong DY; Lai SS; Wang C; Liu Q; Zhang TY; Xue B; Li CJ
FASEB J; 2018 Aug; 32(8):4370-4379. PubMed ID: 29543533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
